Search Results - "Muehlenweg, B"
-
1
Inhibition of urokinase plasminogen activator with a novel enzyme inhibitor, wxc-340, ameliorates endotoxin and surgery-accelerated growth of murine metastases
Published in British journal of cancer (29-01-2007)“…The urokinase plasminogen activator (u-PA) is intimately associated with tumour invasion and metastases. Surgery facilitates accelerated metastatic tumour…”
Get full text
Journal Article -
2
Clinical relevance of matrix metalloproteinase-13 determined with a new highly specific and sensitive ELISA in ascitic fluid of advanced ovarian carcinoma patients
Published in Biological chemistry (01-08-2003)“…Matrix metalloproteinases (MMPs) are involved in many physiological and pathophysiological processes, including tumor cell invasion and metastasis. For one…”
Get more information
Journal Article -
3
Inhibition of the invasion capacity of carcinoma cells by WX‐UK1, a novel synthetic inhibitor of the urokinase‐type plasminogen activator system
Published in International journal of cancer (20-07-2004)“…The overall survival rate of patients suffering from carcinomas has remained poor and nearly unchanged over the last decades. This is mainly due to the…”
Get full text
Journal Article -
4
High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: effects on tumor growth and spread
Published in FEBS letters (25-09-2002)“…Urokinase-type plasminogen activator (uPA) binds with high affinity to its specific cell surface receptor (uPAR) (CD87) via a well-defined sequence within the…”
Get full text
Journal Article -
5
The solution structure and dynamics of human neutrophil gelatinase-associated lipocalin
Published in Journal of molecular biology (28-05-1999)“…Human neutrophil gelatinase-associated lipocalin (HNGAL) is a member of the lipocalin family of extracellular proteins that function as transporters of small,…”
Get full text
Journal Article -
6
Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumours
Published in Expert opinion on biological therapy (01-07-2001)“…There is abundant evidence that the plasminogen activator (PA) system with its key components uPA (urokinase-type plasminogen activator), its cell surface…”
Get more information
Journal Article -
7
Identification of markers for the selection of patients undergoing renal cell carcinoma-specific immunotherapy
Published in Proteomics (Weinheim) (01-06-2003)“…Renal cell carcinoma (RCC) represents the most common malignant tumor in the kidney and is resistant to conventional therapies. The diagnosis of RCC is often…”
Get full text
Journal Article Conference Proceeding -
8
-
9
Identification of a novel urokinase receptor splice variant and its prognostic relevance in breast cancer
Published in Thrombosis and haemostasis (01-04-2003)“…The cellular receptor for urokinase-type plasminogen activator, uPAR, plays a central role in both cell surface-associated proteolysis and cellular adhesion…”
Get more information
Journal Article -
10
Induction of tumor cell death by high hydrostatic pressure as a novel supporting technique in orthopedic surgery
Published in Oncology reports (01-11-2003)“…As vegetative forms of microorganisms are impaired by high hydrostatic pressure (HHP) in the range of 400-600 MPa, the non-thermal inactivation of vegetative…”
Get more information
Journal Article -
11
A novel type of bifunctional inhibitor directed against proteolytic activity and receptor/ligand interaction. Cystatin with a urokinase receptor binding site
Published in The Journal of biological chemistry (27-10-2000)“…Cancer invasion and metastasis is a process requiring a coordinated series of (anti-)adhesive, migratory, and pericellular proteolytic events involving various…”
Get full text
Journal Article -
12
Protein expression of MMP-13, uPA, and PAI-1 in pseudocapsular and interface tissue around implants of loose artificial hip joints and in osteoarthritis
Published in International journal of molecular medicine (01-05-2004)“…Matrix metalloproteinase 13 (MMP-13), urokinase type plasminogen activator (uPA), and plasminogen activator inhibitor type-1 (PAI-1) have been reported to be…”
Get more information
Journal Article -
13
-
14
Interaction of plasminogen activator inhibitor type‐1 (PAI‐1) with vitronectin: Characterization of different PAI‐1 mutants
Published in European journal of biochemistry (01-01-2002)“…The serpin plasminogen activator inhibitor type 1 (PAI‐1) plays an important role in physiological processes such as thrombolysis and fibrinolysis, as well as…”
Get full text
Journal Article -
15
Epitope Mapping of Monoclonal Antibodies Directed to PAI-1 Using PAI-1/PAI-2 Chimera and PAI-1-Derived Synthetic Peptides
Published in Thrombosis research (01-04-2000)“…Plasminogen activator inhibitor type-1 is a key regulatory protein of the fibrinolytic system that is involved in a variety of physiological and…”
Get full text
Journal Article